Healthplan

Products

At Healthplan Pharma (India) Pvt. Ltd. we offer a comprehensive portfolio of high-quality pharmaceutical products designed to support healthcare professionals in delivering effective, reliable, and patient-centric care. Our product range spans key therapeutic areas with a strong focus on mental health, neurology, and supportive care, ensuring clinically relevant solutions across diverse patient needs.

Our Therapeutic Portfolio

Antipsychotics / Antimanic

Antidepressants

Anticonvulsants

Cerebral Activators

Sedatives/tranquilizers/
Anxiolytics

Mood Stabilizers

Drugs used in Peripheral neuropathy

Vitamins

Neuroprotectant

Appetizers

Anti-ulcerants

Anticholinergic

Products

Antipsychotics / Antimanic

Healthplan Pharma offers a focused and reliable range of antipsychotic and antimanic formulations designed to support the effective management of schizophrenia, psychotic disorders, and bipolar affective disorders. Our portfolio includes both typical and atypical antipsychotics, available in multiple strengths and formulations to meet diverse clinical needs.

Amisulpride Formulations

  • Holopride® 50 / 100 / 200 mg – Tablets
    (Amisulpride)
  • Halopride ® 50/100/200 mg – Tablets

(Amisulpride)

 

Designed for the management of psychotic disorders, offering dose flexibility for initiation and maintenance therapy.

Haloperidol Formulations

  • Halodol® 5 / 10 mg – Tablets
    (Haloperidol)

A conventional antipsychotic option for acute and chronic psychotic conditions.

Trifluoperazine Formulations

  • Halocalm® 5 mg – Tablets
    (Trifluoperazine)
  • Halocalm Plus® – Tablets
    (Trifluoperazine + Trihexyphenidyl)

Available as monotherapy and combination therapy to enhance tolerability.

Escitalopram-Based Formulations

  • Holotil® 10 – Tablets
    (Escitalopram 10 mg)
  • Holotil® Plus – Tablets
    (Escitalopram 10 mg + Clonazepam 0.5 mg)

Fluoxetine Formulation

  • Holonet® 20 – Capsules
    (Fluoxetine 20 mg)

Amitriptyline-Based Formulations

  • Meriline® 10/25 – Tablets
    (Amitriptyline 10 mg / 25 mg)
  • Meriline® H – Tablets
    (Amitriptyline 12.5 mg + Chlordiazepoxide 5 mg)
  • Meriline® Plus – Tablets
    (Amitriptyline 25 mg + Chlordiazepoxide 10 mg)

Paroxetine Controlled-Release Formulation

  • Xodep® CR 12.5/25 – Tablets
    (Paroxetine CR 12.5 mg / 25 mg)

Fluvoxamine Formulation

  • Floxa® 50/100 – Tablets
    (Fluvoxamine Maleate 50 mg / 100 mg

Anticonvulsants

Healthplan Pharma offers a focused range of anticonvulsant medicines formulated to support the management of seizure disorders, epilepsy, and related neurological conditions. The portfolio includes immediate-release and controlled-release formulations, providing flexibility for individualized dosing and long-term therapy.

Product Portfolio

Divalproex Sodium (Extended Release)

  • Dova ER® 250 / 500 / 750 – Tablets
    (Divalproex Sodium 250 mg / 500 mg / 750 mg)

Formulated to support stable plasma levels and improved treatment adherence in seizure management.

Sodium Phenytoin

  • Toin® 100 – Tablets
    (Sodium Phenytoin 100 mg)

     

A well-established anticonvulsant option for seizure management.

Cerebral Activators

Healthplan Pharma offers a targeted cerebral activator formulation designed to support cognitive function and neurological performance. This product is commonly used as supportive therapy in conditions associated with impaired cognition, reduced cerebral metabolism, and neurological recovery.

The formulation is available in both tablet and syrup dosage forms, allowing flexibility in administration across different patient populations.

Product Portfolio

Piracetam-Based Formulation

  • Halotam® 800 / Syp – Tablets / Syrup
    (Piracetam 800 mg / syrup formulation)

Halotam® is formulated to support cerebral metabolism and cognitive function and is used as an adjunct in various neurological and cognitive conditions.

Propranolol Hydrochloride

  • Cardiplan® 10 / 40 – Tablets
    (Propranolol Hydrochloride 10 mg / 40 mg)
  • Cardiplan® ER 40 – Tablets
    (Propranolol Hydrochloride Extended-Release 40 mg)

Used in the management of anxiety-related cardiovascular symptoms and stress responses.

Nitrazepam

  • Holonite® 5 / 10 – Tablets
    (Nitrazepam 5 mg / 10 mg)

Used in the management of sleep disorders, as prescribed.

Drugs used in Peripheral neuropathy

Healthplan Pharma offers a targeted formulation to support the management of peripheral neuropathy, a condition commonly associated with diabetes, nutritional deficiencies, and nerve damage. The product is designed to aid in neuropathic symptom management and nerve health support as part of a comprehensive treatment plan prescribed by healthcare professionals.

Product Portfolio

Pregabalin + Methylcobalamin Combination

  • Hologaba-M® – Capsules
    (Pregabalin 75 mg + Methylcobalamin 750 mcg)

This fixed-dose combination is formulated to support relief from neuropathic symptoms while addressing underlying nerve health through vitamin B12 supplementation.

Vita-Plan® Plus – Syrup

A comprehensive multivitamin and mineral formulation supporting nutritional replenishment.

Softener Plus® – Capsules

Designed to support iron supplementation and hematinic requirements.

Vitacal® – Capsules

Formulated to support bone health and calcium metabolism.

Softace Forte® – Capsules

A broad-spectrum antioxidant and micronutrient formulation.

Appetizers

Healthplan Pharma offers a dedicated appetizer formulation designed to support appetite stimulation and improve nutritional intake in patients experiencing reduced appetite. The product is commonly used as supportive therapy in conditions associated with poor appetite, nutritional deficiencies, and general debility, under medical supervision.

The formulation combines an appetite stimulant with supportive agents to aid digestion and nutritional absorption.

Product Portfolio

Cycoplan® – Syrup

Cycoplan® is formulated to help stimulate appetite while supporting digestive function and nutritional balance.

Anticholinergic

Healthplan Pharma offers a focused range of anticholinergic medicines used as supportive therapy in the management of movement-related side effects associated with antipsychotic treatment, including extrapyramidal symptoms. These formulations help improve patient comfort and treatment adherence when prescribed alongside primary psychiatric medications.

Product Portfolio

Triden® – Tablets

Triden® is commonly used to help manage drug-induced extrapyramidal symptoms in patients receiving antipsychotic therapy.

Olanzapine Formulations

  • Oliplan® 2.5 / 5 / 7.5 / 10 mg – Tablets
    (Olanzapine)

Used in the treatment of schizophrenia and bipolar disorder, including acute manic episodes.

Risperidone Formulations

  • Halodone® 2 mg – Tablets
    (Risperidone)
  • Halodone Plus® 2 / 3 mg – Tablets
    (Risperidone + Trihexyphenidyl)

Combination therapy formulated to support symptom control while helping manage extrapyramidal side effects.

Loxapine Hydrochloride Formulations

  • Halopac® 10 / 25 mg – Capsules
    (Loxapine Hydrochloride)
  • Halopac Drop® – Syrup
    (Loxapine Hydrochloride 25 mg)

Offers flexibility for patients requiring alternative dosage forms.

Antidepressants

Healthplan Pharma offers a comprehensive and clinically relevant range of antidepressant formulations designed to support the treatment of depressive disorders, anxiety disorders, and associated psychiatric conditions. The portfolio spans multiple therapeutic classes, providing healthcare professionals with flexibility to individualize treatment based on patient symptoms, severity, and tolerability.

Our antidepressant range includes monotherapies and fixed-dose combinations, available in multiple strengths and dosage forms to support both initiation and maintenance therapy.

Product Portfolio

Imipramine-Based Formulations

  • Meridep® 75 – Tablets
    (Imipramine 75 mg)
  • Meridep® 2 – Tablets
    (Imipramine 25 mg + Diazepam 2 mg

Duloxetine Formulation

  • Doloplan® 20/30 – Tablets
    (Duloxetine 20 mg / 30 mg)

Mirtazapine Formulation

  • Meeta® 15/30 – Tablets
    (Mirtazapine 15 mg / 30 mg)

Sodium Valproate + Valproic Acid (Controlled Release)

  • Sovam CR® 200 / 300 / 500 – Tablets
    (Sodium Valproate IP 333 / 200 / 133.5 mg + Valproic Acid USP 145 / 87 / 58 mg)

Controlled-release combination designed for sustained anticonvulsant effect.

Clonazepam

  • Halopam® 0.25 MD – Tablets
    (Clonazepam USP 0.25 mg)
  • Halopam® 0.5 / 1 / 2 – Tablets
    (Clonazepam 0.5 mg / 1 mg / 2 mg)

Used as adjunctive therapy in seizure disorders and related neurological indications.

Clobazam

  • Cloma® 5 / 10 – Tablets
    (Clobazam 5 mg / 10 mg)

Supports seizure control as monotherapy or adjunctive treatment.

Sedatives/tranquilizers/Anxiolytics

Healthplan Pharma offers a focused range of sedative, tranquilizer, and anxiolytic formulations to support the management of anxiety disorders, stress-related conditions, sleep disturbances, and associated psychosomatic symptoms. The portfolio includes benzodiazepines, beta-blockers, and combination therapies, enabling clinicians to tailor treatment based on symptom profile and patient needs.

Product Portfolio

Alprazolam

  • Halozam® 0.25 / 0.5 – Tablets
    (Alprazolam 0.25 mg / 0.50 mg)

Used in the management of anxiety and panic disorders.

Propranolol + Alprazolam Combinations

  • Pranol® – Tablets
    (Propranolol Hydrochloride 20 mg + Alprazolam 0.25 mg)
  • Pranol® H – Tablets
    (Propranolol Hydrochloride 10 mg + Alprazolam 0.25 mg)

Combination therapy designed to address both somatic and psychological symptoms of anxiety.

Lorazepam

  • Meripose® 1/2 – Tablets
    (Lorazepam 0.5 mg)

Commonly used for short-term relief of anxiety and insomnia associated with anxiety.

Mood Stabilizers

Healthplan Pharma offers a focused range of mood stabilizer formulations designed to support the long-term management of mood disorders, particularly bipolar affective disorder. These products are formulated to help stabilize mood fluctuations and support maintenance therapy under medical supervision.

Product Portfolio

Lithium Carbonate (Sustained Release)

  • Lithotab® 400 SR – Tablets
    (Lithium Carbonate Sustained-Release 400 mg)
  • Lithotab® 450 SR – Tablets
    (Lithium Carbonate Sustained-Release 450 mg)

These sustained-release formulations are designed for use in the maintenance treatment of mood disorders, as prescribed by healthcare professionals.

Vitamins

Healthplan Pharma offers a comprehensive range of vitamin and nutritional supplement formulations designed to support general health, nutritional balance, and specific deficiency states. The portfolio includes multivitamin syrups and capsule formulations, developed to complement clinical care across different age groups and health needs.

Product Portfolio

Multivitamin Syrups

Vita-Plan® – Syrup

Formulated to support overall nutritional supplementation and vitamin balance.

Neuroprotectant

Healthplan Pharma offers a specialized neuroprotectant formulation designed to support nerve health and neurological function. The product is formulated to aid in conditions associated with nerve damage, oxidative stress, and nutritional deficiencies, and is commonly used as supportive therapy under medical supervision.

This formulation combines neurotropic vitamins, antioxidants, and trace elements, reflecting a comprehensive approach to neurological support.

Product Portfolio

BPlus® – Capsules

BPlus® is formulated to support nerve regeneration, antioxidant defense, and metabolic balance, and is commonly prescribed as adjunct therapy in neurological and neuropathic conditions.

Anti- ulcerant

Healthplan Pharma offers a targeted anti-ulcerant formulation designed to support the management of acid-related gastrointestinal disorders. The product is formulated to help reduce gastric acid secretion while supporting gastric motility, aiding symptom relief and patient comfort as part of prescribed therapy.

Product Portfolio

Docid-DSR® – Capsules

Docid-DSR® combines a proton pump inhibitor with a prokinetic agent to support effective management of gastro-esophageal reflux disease (GERD), acid peptic disorders, and related conditions.

Halodrin® 5 – Tablets

Halodrin® 5 supports the management of movement disorders and muscle rigidity associated with antipsychotic-induced side effects.